Characterization of Individuals Taking Part in Low Dose Computed Tomography (LDCT) Screening Program

Moizs, Mariann; Bajzik, Gábor; Lelovics, Zsuzsanna; Strausz, J.; Rakvács, Marianna; Zádori, Péter; Kov́acs, Árṕad; Romics, Imre

doi:10.1007/s12253-015-9929-4

Cited by 3 publications

(2 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Much of the evidence for both non-attendance and methods employed to improve adherence comes from the USA, which has the longest Western implementation period for a national programme. Navigators have been identified as an important way to improve adherence [205,207,208]. It is established that either nurse navigators or lay patient navigators improve baseline participation.…”

Section: Participant and Programme Features Important In Non-attendancementioning

confidence: 99%

Developing a pan-European technical standard for a comprehensive high-quality lung cancer computed tomography screening programme: an ERS technical standard

et al. 2023

View full text Add to dashboard Cite

Screening for lung cancer with low radiation dose computed tomography (LDCT) has a strong evidence base. The European Council adopted a recommendation in November 2022 that lung cancer screening be implemented using a stepwise approach. The imperative now is to ensure that implementation follows an evidence-based process that delivers clinical and cost effectiveness. This ERS Taskforce was formed to provide a technical standard for a high-quality lung cancer screening program.MethodA collaborative group was convened to include members of multiple European societies (see below). Topics were identified during a scoping review and a systematic review of the literature was conducted. Full text was provided to members of the group for each topic. The final document was approved by all members and the ERS Scientific Advisory Committee.ResultsTen topics were identified representing key components of a screening program. The action on findings from the LDCT were not included as they are addressed by separate international guidelines (nodule management and clinical management of lung cancer) and by a linked taskforce (incidental findings). Other than smoking cessation, other interventions that are not part of the core screening process were not included (e.g.pulmonary function measurement). Fifty-three statements were produced and areas for further research identified.ConclusionThis European collaborative group has produced a technical standard that is a timely contribution to implementation of LCS. It will serve as a standard that can be used, as recommended by the European Council, to ensure a high quality and effective program.

show abstract

Section: Participant and Programme Features Important In Non-attendancementioning

confidence: 99%

Developing a pan-European technical standard for a comprehensive high-quality lung cancer computed tomography screening programme: an ERS technical standard

et al. 2023

View full text Add to dashboard Cite

show abstract

“…The free choice to participate or not, also seems to be important. Individuals who had to undergo screening as an obligation due to health regulations were significantly less likely to participate in voluntary screening programs (42).…”

Section: Recruitment: General Barriersmentioning

confidence: 99%

Lung cancer screening: targeting the hard to reach—a review

Hal¹,

Garcia²

2021

Transl Lung Cancer Res

View full text Add to dashboard Cite

Lung cancer (LC) is the leading cause of cancer death in the USA for both men and women (1). Also worldwide, LC is the commonest cause of cancer death (2). Of all LC cases, smoking is implicated in more than 90% and prognosis is poor, with mortality close to 85% (3).However, the earlier the stage at which LC is detected, the better the prognosis. In November 2011, the first large multicenter randomized control trial-the National Lung Screening Trial (NLST) in the USA-released their results that showed that screening with chest low-dose computed tomography (LDCT) could reduce LC mortality by 20% (4,5). In the meantime, the NELSON trial in The Netherlands and Belgium also released its results (6). They found that screening with chest LDCT can reduce cause-Review Article on Lung Cancer Screening

show abstract

Predictors of participant nonadherence in lung cancer screening programs: a systematic review and meta-analysis

et al. 2020

View full text Add to dashboard Cite

Characterization of Individuals Taking Part in Low Dose Computed Tomography (LDCT) Screening Program

Abstract: IG/03833/2012.

Cited by 3 publications

References 15 publications

Developing a pan-European technical standard for a comprehensive high-quality lung cancer computed tomography screening programme: an ERS technical standard

Developing a pan-European technical standard for a comprehensive high-quality lung cancer computed tomography screening programme: an ERS technical standard

Lung cancer screening: targeting the hard to reach—a review

Predictors of participant nonadherence in lung cancer screening programs: a systematic review and meta-analysis

Contact Info

Product

Resources

About